IL-12 DNA (formulated with bupivacaine)

TERMINATED · PHASE1 · HIV Infections

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.